Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experience
Objective To examine real-world treatment persistence, colectomy-free survival and treatment switching patterns in UK patients with ulcerative colitis (UC) prescribed golimumab or adalimumab.Design This was a retrospective chart review study in adult patients diagnosed with UC using data from 16 Nat...
Saved in:
| Main Authors: | Sami Hoque, Christopher M Black, Amy Puenpatom, Simona Boccaletti, Chloe Green, Jenna Roberts, Ivana Rajkovic, Gary Milligan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-12-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/7/1/e000476.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease
by: María Calvo-Arbeloa, et al.
Published: (2020-03-01) -
Severe and Extensive Enteritis following Colectomy for Ulcerative Colitis
by: Greg Rosenfeld, et al.
Published: (2012-01-01) -
20944. NEUROSARCOIDOSIS-LIKE SECUNDARIA A GOLIMUMAB
by: A. Garre Lerma, et al.
Published: (2024-11-01) -
Lanreotide Autogel in the Treatment of Persistent Diarrhea following a Total Colectomy
by: Patrick Schoeters, et al.
Published: (2015-01-01) -
Post-colectomy enteritis—a rare complication in a patient with ulcerative colitis
by: Julia Wanzl, et al.
Published: (2025-01-01)